SCM
CRBU icon

Sterling Capital Management’s Caribou Biosciences CRBU Stock Holding History

Sterling Capital Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.26K Buy
+1,851
New +$3.66K ﹤0.01% 2828
2025
Q2 		– Sell
-1,478
Closed -$1.35K – 3292
2025
Q1 		$1.35K Sell
1,478
-1,316
-47% -$1.71K ﹤0.01% 2717
2024
Q4 		$4.44K Buy
2,794
+2,539
+996% +$5.11K ﹤0.01% 2518
2024
Q3 		$500 Buy
+255
New +$522 ﹤0.01% 2868

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sterling Capital Management's CRBU Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Caribou Biosciences (CRBU) in Q2 2026: 1,851 shares worth $3.26K. The stake represents ﹤0.01% of the portfolio and ranks #2828 among its holdings. This is a return to the name: Sterling Capital Management previously reported a position in CRBU as recently as Q1 2025.

Sterling Capital Management first reported a position in CRBU in Q3 2024 and has held it in 4 quarters since. The position peaked at $4.44K in Q4 2024. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Sterling Capital Management held 1,851 shares of Caribou Biosciences worth $3.26K as of Q2 2026.
  • Caribou Biosciences was a new Sterling Capital Management position in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2828 holding.
  • Sterling Capital Management first reported a position in Caribou Biosciences in Q3 2024 and has held it in 4 quarters since.
  • Sterling Capital Management's Caribou Biosciences position peaked at $4.44K in Q4 2024.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.